Kyivmedpreparat Logo

Kyivmedpreparat

A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.

KMED | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000106140
LEI:
Country:
Ukraine
Address:
139 Saksaganskogo Str., 01032 Kyiv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kyivmedpreparat, a part of Arterium Corporation, is a pharmaceutical company that manufactures a wide range of medicinal products. The company is a leading national producer of antibacterial drugs and also offers a broad portfolio of generic and original medicines. Its products are manufactured in various forms, including powders for injection, tablets, capsules, soft medicinal products, and granules for oral solutions. The company focuses on developing patient-centric solutions, providing high-quality medicines, and supporting patients throughout their treatment.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kyivmedpreparat filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kyivmedpreparat

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kyivmedpreparat via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT

Talk to a Data Expert

Have a question? We'll get back to you promptly.